Search

Kenny is the adaptor protein for ubiquitin-dependent mitophagy in Drosophila melanogaster.

Research Autophagy reports March 4, 2026

Advanced Parkinson's disease treatment patterns in Italy: results from a multicenter observational study.

Research Annals of medicine March 4, 2026

Adaptations in Nuclear Neurology Procedures for Elderly Patients: A Survey of Nuclear Medicine Technologists in Portugal.

Research Journal of nuclear medicine technology March 4, 2026

Digital Technologies for Symptom Monitoring in Parkinson Disease.

Research Current neurology and neuroscience reports March 4, 2026

Parkinson's Improvement Activated by Hula Understanding

Trial N/A Completed March 3, 2026

Effect of Striatal Temporal Interference Stimulation on Language Processing in Neurodegenerative Diseases

Trial N/A Recruiting March 3, 2026

The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients

Trial N/A Recruiting March 2, 2026

Percept Transitions in FOG and PD

Trial N/A Recruiting March 2, 2026

A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease

Trial Phase 2 Active, not recruiting March 2, 2026

Udall Project 2 Aim 2A&C

Trial N/A Recruiting March 2, 2026

Parkinson's Disease: Enhancing Physical Therapy With Brain Stimulation for Treating Postural Instability.

Trial N/A Active, not recruiting March 2, 2026

Sleep-specific DBS Therapy in Parkinson's Disease

Trial N/A Recruiting March 2, 2026

Gait and Freezing in Parkinson’s

News Brian Grant Foundation March 2, 2026

N-acetyl-l-leucine lowers α-synuclein levels and improves synaptic function in Parkinson's disease models.

Research The Journal of clinical investigation March 2, 2026

Risk Adjustment for Alzheimer Disease and Related Dementias in Medicare Advantage and Health Care Experiences.

Research JAMA network open March 2, 2026

Effects of rTSMS Associated With Treadmill Training in Patients With Parkinson's Disease

Trial N/A Completed March 1, 2026

The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease

Trial N/A Recruiting March 1, 2026

IMPACT 360 for Parkinson's Disease

Trial Phase 2 Recruiting March 1, 2026

Terazosin and Parkinson's Disease Extension Study

Trial Phase 2 Active, not recruiting March 1, 2026

Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)

Trial Phase 2 Active, not recruiting March 1, 2026